Navigation Links
Cell Therapeutics to Re-submit Pixantrone NDA in Consideration for Accelerated Approval in Accordance with Guidance from FDA's Office of New Drugs
Date:5/2/2011

ffuse large NHL and/or other tumors as determined by the FDA and/or the EMA, whether alone or in combination with rituximab, that accelerated approval by the FDA of pixantrone may not be possible or occur, that CTI may not be able to address satisfactorily the two key matters raised by the OND or other matters raised by the OND and/or the FDA, that CTI's interpretation of the guidance provided by the OND may be different than the intent of the OND, that the OND may change its guidance, that the PIX301 study may not be deemed successful, that a re-review of the pixantrone NDA may not be warranted and, if warranted, that the FDA may find pixantrone to not be safe and/or effective, that the PIX301 study may still be deemed to be a failed study, that the FDA may require an additional clinical trial of pixantrone, that if CTI conducts an additional clinical trial, it may not demonstrate the safety and effectiveness of pixantrone, that the FDA may not provide CTI with a meeting quickly, that CTI may not be able to provide satisfactory information in response to the FDA's Complete Response, that CTI may not be able to re-submit the pixantrone NDA quickly, CTI's ability to continue to raise capital as needed to fund its operations, competitive factors, technological developments, costs of developing, producing and selling pixantrone, and the risk factors listed or described from time to time in CTI's filings with the Securities and Exchange Commission including, without limitation, CTI's most recent filings on Forms 10-K, 10-Q and 8-K. Except as may be required by law, CTI does not intend to update or alter its forward-looking statements whether as a result of new information, future events, or otherwise.

Media Contact:
Dan Eramian
T: 206.272.4343
C: 206.854.1200
E: deramian@ctiseattle.com


Investors Contact:
Ed Bell
T: 206.272.4345
Lindsey Jesch Logan

'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Grifols and Talecris Biotherapeutics Announce the Signing of a Consent Agreement With FTC Staff
2. Pearl Therapeutics to Present Complete PT003 Results from Phase 2b COPD Study in a Late-Breaker Session at the American Thoracic Society Annual Meeting
3. Halozyme Therapeutics to Host First Quarter 2011 Financial Results Conference Call on May 6
4. United Therapeutics Corporation Reports First Quarter 2011 Financial Results
5. Cell Therapeutics, Inc. Announces Institutional Investors Purchase Approximately $16.0 Million of Preferred Stock and Warrants
6. Prime Therapeutics President and CEO Eric Elliott Delivers Speech at University of Minnesota College of Pharmacy Dialogues in Managed Care Leadership 2011
7. Cell Therapeutics, Inc. Reports First Quarter Accomplishments and Financial Results
8. JumpStart Ventures Invests in Cleveland-based SPR Therapeutics
9. New Biopharmaceutical Company to Accelerate Delivery of Vaccines and Protein Therapeutics
10. Vista Partners Updates Coverage on Opexa Therapeutics, Inc.; Maintains Target Price of $6.50
11. Mersana Therapeutics Appoints Michael A. Metzger as EVP & COO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... Aug. 27, 2015  BioElectronics Corporation (OTC Pink: BIEL), the ... three abstracts featuring the use of ActiPatch®, its novel ... th Congress of the European Pain Federation EFIC®, ... September 2015. The Company will also be exhibiting at ... Gianluca Bagnato , department clinical and experimental rheumatology from ...
(Date:8/27/2015)... Aug. 27, 2015   Americord Registry , a ... and placenta tissue banking company, announced today ... e-commerce website. This new website makes the expecting parent,s ... interactive shopping cart and checkout process. Logo ... blood banking websites make this service difficult to purchase ...
(Date:8/27/2015)... 27, 2015  Zimmer Biomet Holdings, Inc. (NYSE and ... that it will be participating in the Goldman Sachs ... Sachs offices in London on ... Founded in 1927 and headquartered in Warsaw, ... in musculoskeletal healthcare.  We design, manufacture and market orthopaedic ...
Breaking Medicine Technology:BioElectronics Selected to Present its Pain Research and Devices at the European Pain Federation Conference 2Cord Blood Bank Revolutionizes Process of Online Cord Blood Banking 2
... Symmetry Medical Inc. (NYSE: SMA ), a leading ... and other medical markets, announced today that it has entered ... November 3, 2010.  The credit facility includes an "accordion feature" ... million. The credit facility has a term of five years. ...
... Nov. 3, 2010 Aethlon Medical, Inc. (OTC ... in developing therapeutic filtration devices to address infectious ... present tomorrow at the at the Singular Research ... Los Angeles. (Photo:   http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b ) ...
Cached Medicine Technology:Symmetry Medical Closes $200 Million Credit Facility 2Symmetry Medical Closes $200 Million Credit Facility 3Aethlon Medical to Present at the Singular Research Fifth Annual 'Best of the Uncovereds Conference' 2Aethlon Medical to Present at the Singular Research Fifth Annual 'Best of the Uncovereds Conference' 3Aethlon Medical to Present at the Singular Research Fifth Annual 'Best of the Uncovereds Conference' 4
(Date:8/27/2015)... (PRWEB) , ... August 28, 2015 , ... This new ... ensure that patients are always scheduled for the next visit, their authorizations are in ... here . , According to Jason Barnes, COO for Genesis Chiropractic Software, growing a ...
(Date:8/27/2015)... Mesa, CA (PRWEB) , ... August 27, 2015 , ... ... to get help, leaving weeks or months later, relapsing and returning again, all at ... under the influence while in sober living homes or soon after leaving facilities who ...
(Date:8/27/2015)... Los Angeles, CA (PRWEB) , ... August 27, 2015 , ... ... Diabetes Association and the American Heart Association have released new guidelines to educate doctors ... that the last update to these particular guidelines came in 2007, so the new ...
(Date:8/27/2015)... ... 27, 2015 , ... In mid-May, Logistics Trust, Inc. (“Logistics ... launch of its Doobster platform, a HIPAA-compliant mobile application that allows medical marijuana ... phones and tablets. Well, Doobster, “The App That Delivers!” is here! ...
(Date:8/27/2015)... ... August 27, 2015 , ... The Naderi Center is proud to announce ... cutting-edge, noninvasive procedure to improve submental fat. The first and only Food and ... surgery. Dr. Kulak is the only Board Certified surgeon in the D.C., Maryland, ...
Breaking Medicine News(10 mins):Health News:A New Webinar Teaches Chiropractors How to Use Compliance Alerts to Manage Patient Relationships 2Health News:National Screenings of Documentary Indicate Burgeoning Questions about the Effectiveness of Addiction Treatment Facilities 2Health News:National Screenings of Documentary Indicate Burgeoning Questions about the Effectiveness of Addiction Treatment Facilities 3Health News:Article on New Diabetic Care Guidelines Shines Brightly on Weight Loss Surgery, notes Beverly Hills Physicians 2Health News:Article on New Diabetic Care Guidelines Shines Brightly on Weight Loss Surgery, notes Beverly Hills Physicians 3Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 2Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 3Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 4Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 5Health News:Noninvasive Double Chin Elimination Now Available in Herndon and Chevy Chase 2Health News:Noninvasive Double Chin Elimination Now Available in Herndon and Chevy Chase 3
... medical records to be provided at locations throughout ... entered into a clinical collaboration with MinuteClinic, the ... in the United States, at several locations inside ... provide a convenient, seven-day-a-week option for those with ...
... eminent orthopaedic surgeon at the University of Brighton Medical School has ... research on a new orthopaedic prosthesis for shoulder reconstruction. , ... ... Keith Borowsky, an eminent orthopaedic surgeon at the University of Brighton ...
... Court for the Commonwealth of MassachusettsVANCOUVER, Feb. 12 ... ; TSX: QLT) announced that on February 11, ... Massachusetts General Hospital ("MGH"), filed a complaint in ... against QLT Phototherapeutics (Canada), Inc. QLT Phototherapeutics (Canada), ...
... gender also affect chances of having debilitating headaches , , THURSDAY, ... risk of migraine headaches in young and middle-aged adults, suggests ... gender and the way body fat was distributed affected migraine ... were more likely to have migraines than those with smaller ...
... The Bay, a regional resource for hospice and ... care at no charge to all healthcare professionals ... in March. CEUs are available. The ongoing trainings ... in Larkspur. For the schedule of trainings, which ...
... BTEL) announced results for its second quarter ended,December 31, ... diluted share,on revenues of $3,186,000. This compares to net ... of $2,859,000 for the second quarter of last,year. For ... net earnings of,$617,000, or $0.22 per diluted share, on ...
Cached Medicine News:Health News:Cleveland Clinic Enters into Agreement with MinuteClinic 2Health News:Cleveland Clinic Enters into Agreement with MinuteClinic 3Health News:Cleveland Clinic Enters into Agreement with MinuteClinic 4Health News:Force Tester Shoulders The Burden 2Health News:QLT announces that it is named as a defendant in an action 2Health News:QLT announces that it is named as a defendant in an action 3Health News:Belly Fat May Make Migraines More Likely 2Health News:Hospice By The Bay Offers Health Care Professionals Free Training in End-of-Life Care 2Health News:Hospice By The Bay Offers Health Care Professionals Free Training in End-of-Life Care 3Health News:Biotel Announces Profitable Second Quarter Ended December 31, 2008 2
... the first polypropylene mesh specifically designed ... directly addresses the critical issues associated ... delivers maximum visibility, enhanced maneuverability and ... through the trocar.,Visilex mesh is the ...
... technique, recommended for the treatment of ... direct inguinal hernias, provides significant advantages ... less overall dissection and is utilized ... The result is increased patient comfort, ...
... longest available wavelength with a unique flat ... efficacy. The unique flat beam profile consistently ... all targeted structures. The Lyra-I uniquely avoids ... Lyra-I patients are protected by patented continuous ...
... nonabsorbable knitted product for use in ... a highly flexible and compliant material ... surgical adaptability, along with maximal porosity ... Mesh is constructed from polyethylene terephthalate, ...
Medicine Products: